← Browse by Condition
Medical Condition
hepatocellular carcinoma hcc
Total Trials
19
Recruiting Now
19
Trial Phases
Phase 2, Phase 4, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for hepatocellular carcinoma hcc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — hepatocellular carcinoma hcc Clinical Trials
How many clinical trials are currently recruiting for hepatocellular carcinoma hcc?
ClinicalMetric currently tracks 19 actively recruiting clinical trials for hepatocellular carcinoma hcc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hepatocellular carcinoma hcc?
hepatocellular carcinoma hcc research spans Phase 1 (4 trials), Phase 2 (7 trials), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hepatocellular carcinoma hcc clinical trial?
Eligibility criteria for hepatocellular carcinoma hcc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 7
Phase 3 2
Phase 4 1
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06605664 Phase 2
Recruiting
Enrollment
45 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT06594744 Phase 4
Recruiting
Enrollment
120 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
NCT06644937 Phase 2, Phase 3
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Zhujiang Hospital
NCT07154082 Phase 2
Recruiting
Enrollment
27 pts
Location
China
Sponsor
Wei Zhang
NCT06979219
Recruiting
Enrollment
146 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
NCT06636435 Phase 1
Recruiting
Enrollment
66 pts
Location
Japan
Sponsor
Chiome Bioscience Inc.
NCT07192185 Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Sun Yat-sen University
NCT07224750
Recruiting
Enrollment
1,000 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07476651
Recruiting
Enrollment
30 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
NCT06741020 Phase 1, Phase 2
Recruiting
Enrollment
10 pts
Location
China
Sponsor
Zhejiang Cancer Hospital
NCT06689540 Phase 1
Recruiting
Enrollment
14 pts
Location
China
Sponsor
Shen Lin
NCT07303712
Recruiting
Enrollment
12 pts
Location
United States
Sponsor
Palo Alto Veterans Institute f...
NCT07495215 Phase 1, Phase 2
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Yinghua Xu
NCT07322848 Phase 3
Recruiting
Enrollment
206 pts
Location
China
Sponsor
First Affiliated Hospital, Sun...
NCT06876753
Recruiting
Enrollment
300 pts
Location
China
Sponsor
Zhongda Hospital
NCT07265271
Recruiting
Enrollment
600 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07170345
Recruiting
Enrollment
400 pts
Location
China
Sponsor
Chinese Academy of Sciences
NCT06762782 Phase 2
Recruiting
Enrollment
276 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07291141
Recruiting
Enrollment
600 pts
Location
Sweden
Sponsor
Mattias Ekstedt
Related Conditions
esophageal varices (1) solid tumors (1) malignant melanoma (1) pediatric cancer (1) cholangiocarcinoma (1) pancreatic ductal adenocarcinoma pdac (1) esophageal squamous cell carcinoma escc (1) gastric cancer gc (1) colorectal cancer screening (1) radioembolization (1) intrahepatic cholangiocarcinoma icc (1) liver metastasis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology